182 related articles for article (PubMed ID: 19064563)
1. Effect of insulin-like growth factor gene polymorphisms alone or in interaction with diabetes on the risk of pancreatic cancer.
Suzuki H; Li Y; Dong X; Hassan MM; Abbruzzese JL; Li D
Cancer Epidemiol Biomarkers Prev; 2008 Dec; 17(12):3467-73. PubMed ID: 19064563
[TBL] [Abstract][Full Text] [Related]
2. Insulin-like growth factor axis gene polymorphisms modify risk of pancreatic cancer.
Dong X; Li Y; Tang H; Chang P; Hess KR; Abbruzzese JL; Li D
Cancer Epidemiol; 2012 Apr; 36(2):206-11. PubMed ID: 21852217
[TBL] [Abstract][Full Text] [Related]
3. Insulin-like growth factor axis gene polymorphisms and clinical outcomes in pancreatic cancer.
Dong X; Javle M; Hess KR; Shroff R; Abbruzzese JL; Li D
Gastroenterology; 2010 Aug; 139(2):464-73, 473.e1-3. PubMed ID: 20416304
[TBL] [Abstract][Full Text] [Related]
4. Case-control study of diabetes-related genetic variants and pancreatic cancer risk in Japan.
Kuruma S; Egawa N; Kurata M; Honda G; Kamisawa T; Ueda J; Ishii H; Ueno M; Nakao H; Mori M; Matsuo K; Hosono S; Ohkawa S; Wakai K; Nakamura K; Tamakoshi A; Nojima M; Takahashi M; Shimada K; Nishiyama T; Kikuchi S; Lin Y
World J Gastroenterol; 2014 Dec; 20(46):17456-62. PubMed ID: 25516658
[TBL] [Abstract][Full Text] [Related]
5. 5,10-Methylenetetrahydrofolate reductase polymorphisms and the risk of pancreatic cancer.
Li D; Ahmed M; Li Y; Jiao L; Chou TH; Wolff RA; Lenzi R; Evans DB; Bondy ML; Pisters PW; Abbruzzese JL; Hassan MM
Cancer Epidemiol Biomarkers Prev; 2005 Jun; 14(6):1470-6. PubMed ID: 15941958
[TBL] [Abstract][Full Text] [Related]
6. Common genetic variation in IGF1 and prostate cancer risk in the Multiethnic Cohort.
Cheng I; Stram DO; Penney KL; Pike M; Le Marchand L; Kolonel LN; Hirschhorn J; Altshuler D; Henderson BE; Freedman ML
J Natl Cancer Inst; 2006 Jan; 98(2):123-34. PubMed ID: 16418515
[TBL] [Abstract][Full Text] [Related]
7. The XPD Asp312Asn and Lys751Gln polymorphisms, corresponding haplotype, and pancreatic cancer risk.
Jiao L; Hassan MM; Bondy ML; Abbruzzese JL; Evans DB; Li D
Cancer Lett; 2007 Jan; 245(1-2):61-8. PubMed ID: 16458430
[TBL] [Abstract][Full Text] [Related]
8. Common genetic variation in IGF1, IGFBP1 and IGFBP3 and ovarian cancer risk.
Terry KL; Tworoger SS; Gates MA; Cramer DW; Hankinson SE
Carcinogenesis; 2009 Dec; 30(12):2042-6. PubMed ID: 19858071
[TBL] [Abstract][Full Text] [Related]
9. Inflammation, genetic polymorphisms in proinflammatory genes TNF-A, RANTES, and CCR5, and risk of pancreatic adenocarcinoma.
Duell EJ; Casella DP; Burk RD; Kelsey KT; Holly EA
Cancer Epidemiol Biomarkers Prev; 2006 Apr; 15(4):726-31. PubMed ID: 16614115
[TBL] [Abstract][Full Text] [Related]
10. Re-evaluation of ABO gene polymorphisms detected in a genome-wide association study and risk of pancreatic ductal adenocarcinoma in a Chinese population.
Xu HL; Cheng JR; Zhang W; Wang J; Yu H; Ni QX; Risch HA; Gao YT
Chin J Cancer; 2014 Feb; 33(2):68-73. PubMed ID: 23816557
[TBL] [Abstract][Full Text] [Related]
11. Antioxidant genes, diabetes and dietary antioxidants in association with risk of pancreatic cancer.
Tang H; Dong X; Day RS; Hassan MM; Li D
Carcinogenesis; 2010 Apr; 31(4):607-13. PubMed ID: 20097730
[TBL] [Abstract][Full Text] [Related]
12. Body mass index and obesity- and diabetes-associated genotypes and risk for pancreatic cancer.
Tang H; Dong X; Hassan M; Abbruzzese JL; Li D
Cancer Epidemiol Biomarkers Prev; 2011 May; 20(5):779-92. PubMed ID: 21357378
[TBL] [Abstract][Full Text] [Related]
13. Polymorphisms of cytochrome P4501A2 and N-acetyltransferase genes, smoking, and risk of pancreatic cancer.
Li D; Jiao L; Li Y; Doll MA; Hein DW; Bondy ML; Evans DB; Wolff RA; Lenzi R; Pisters PW; Abbruzzese JL; Hassan MM
Carcinogenesis; 2006 Jan; 27(1):103-11. PubMed ID: 15987714
[TBL] [Abstract][Full Text] [Related]
14. Association between insulin-like growth factor-1 polymorphisms and stomach cancer risk in a Japanese population.
Ennishi D; Shitara K; Ito H; Hosono S; Watanabe M; Ito S; Sawaki A; Yatabe Y; Yamao K; Tajima K; Tanimoto M; Tanaka H; Hamajima N; Matsuo K
Cancer Sci; 2011 Dec; 102(12):2231-5. PubMed ID: 21854509
[TBL] [Abstract][Full Text] [Related]
15. Genotypes and haplotypes in the insulin-like growth factors, their receptors and binding proteins in relation to plasma metabolic levels and mammographic density.
Biong M; Gram IT; Brill I; Johansen F; Solvang HK; Alnaes GI; Fagerheim T; Bremnes Y; Chanock SJ; Burdett L; Yeager M; Ursin G; Kristensen VN
BMC Med Genomics; 2010 Mar; 3():9. PubMed ID: 20302654
[TBL] [Abstract][Full Text] [Related]
16. A population-based study of IGF axis polymorphisms and the esophageal inflammation, metaplasia, adenocarcinoma sequence.
McElholm AR; McKnight AJ; Patterson CC; Johnston BT; Hardie LJ; Murray LJ;
Gastroenterology; 2010 Jul; 139(1):204-12.e3. PubMed ID: 20403354
[TBL] [Abstract][Full Text] [Related]
17. Associations among IRS1, IRS2, IGF1, and IGFBP3 genetic polymorphisms and colorectal cancer.
Slattery ML; Samowitz W; Curtin K; Ma KN; Hoffman M; Caan B; Neuhausen S
Cancer Epidemiol Biomarkers Prev; 2004 Jul; 13(7):1206-14. PubMed ID: 15247132
[TBL] [Abstract][Full Text] [Related]
18. Interaction of polymorphisms in mitotic regulator genes with cigarette smoking and pancreatic cancer risk.
Jang JH; Cotterchio M; Borgida A; Liu G; Gallinger S; Cleary SP
Mol Carcinog; 2013 Nov; 52 Suppl 1(0 1):E103-9. PubMed ID: 23908141
[TBL] [Abstract][Full Text] [Related]
19. Insulin-Like Growth Factor 1 (IGF1) Pathway Member Polymorphisms Are Associated with Risk and Prognosis of Chondrosarcoma.
Xie H; Mao JS; Hu WF
Med Sci Monit; 2020 Apr; 26():e923853. PubMed ID: 32314747
[TBL] [Abstract][Full Text] [Related]
20. A population-based study of the Arg399Gln polymorphism in X-ray repair cross- complementing group 1 (XRCC1) and risk of pancreatic adenocarcinoma.
Duell EJ; Holly EA; Bracci PM; Wiencke JK; Kelsey KT
Cancer Res; 2002 Aug; 62(16):4630-6. PubMed ID: 12183419
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
